All In Biotech

Free tool

FAERS Monitor: Emerphed

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 213407 or its brand name (Emerphed, Ephedrine Sulfate). Reports on generic versions are filed under their own applications.

Reports

134

Serious

101

75% of reports

Hospitalization

41

Death reported

20

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective15
  • cardiac arrest13
  • toxicity to various agents13
  • drug abuse12
  • overdose12
  • respiratory arrest11
  • administration related reaction10
  • hypotension10
  • off label use10
  • drug hypersensitivity9
  • nausea8
  • pain8
  • anxiety7
  • asthenia7
  • back pain6

Reports by year received

View as table
YearReports
20064
20084
20092
20106
20112
20121
20131
20144
20151
20162
20175
201817
201913
202010
20216
20228
202318
202415
20255
202610

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,025 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
administration related reactionSignal108493.04599.072,701
respiratory arrestSignal1162.735.6608
cardiac arrestSignal1324.714.7274
drug abuseSignal1222.613.2228
toxicity to various agentsSignal1312.17.2122
overdoseSignal128.75.175
hypotensionSignal107.84.353
drug hypersensitivitySignal97.33.943
back painSignal64.11.911
anxietySignal73.91.912
astheniaSignal72.91.47
pain82.01.03
off label use101.81.03
drug ineffective151.81.15
nausea81.60.81

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.